Nonpermissive Skin Environment Impairs Nerve Regeneration in Diabetes via Sec31a
- 5 April 2022
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 91 (6) , 821-833
Abstract
Objective: Although the microenvironment for peripheral nerve regeneration is permissive, such a mechanism is defective in diabetes, and the molecular mediators remain elusive. [Correction added on May 11, 2022, after first online publication: In the preceding sentence, “is ok” was changed to “is defective”.] This study aimed to (1) investigate the relationship between skin innervation and collagen pathology in diabetic neuropathy and to (2) clarify the molecular alterations that occur in response to hyperglycemia and their effects on axon regeneration.Methods: We addressed this issue using two complementary systems: (1) human skin from patients with diabetic neuropathy and to (2) a coculture model of human dermal fibroblasts (HDFs) with rat dorsal root ganglia neurons in the context of intrinsic neuronal factor and extrinsic microenvironmental collagen and its biosynthetic pathways.Results: In diabetic neuropathy, the skin innervation of intraepidermal nerve fiber density (IENFd), a measure of sensory nerve degeneration, was reduced with similar expression of a growth associated protein 43, a marker of nerve regeneration. In contrast, the content and packing of collagen in the diabetic skin became more rigid than the control skin. Sec31a, a protein that regulates the collagen biosynthetic pathway, was upregulated and inversely correlated with IENFd. In the cell model, activated HDFs exposed to high‐glucose medium enhanced the expression of Sec31a and collagen I through the activation of transforming growth factor β, a profibrotic molecule. Sec31a upregulation impaired neurite outgrowth. This effect was reversed by silencing Sec31a expression and neurite outgrowth was resumed.Interpretation: The current study provides evidence that Sec31a plays a key role in inhibiting nerve regeneration in diabetic neuropathy. ANN NEUROL 2022;91:821–833Keywords
Funding Information
- I-Shou University (ISU‐109‐IUC‐07, ISU 110‐S03)
- Ministry of Education (107 L9014‐2)
- Ministry of Science and Technology, Taiwan (107‐2320‐B‐002‐043‐MY3, 107‐3017‐F‐002‐002, 110‐2320‐B‐214‐002)
- National Taiwan University Hospital (111‐UN0020, UN109‐013)
This publication has 46 references indexed in Scilit:
- Transforming Growth Factor–β Induces Extracellular Matrix Protein Cross-Linking Lysyl Oxidase (LOX) Genes in Human Trabecular Meshwork CellsInvestigative Ophthalmology & Visual Science, 2011
- Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomyBrain, 2011
- Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemiaArchives of Medical Science, 2011
- Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in DiabetesDiabetes, 2009
- Reactivation of Optic Nerve Head Astrocytes by TGF-β2 and H2O2Is Accompanied by Increased Hsp32 and Hsp47 ExpressionInvestigative Ophthalmology & Visual Science, 2009
- Transforming growth factor-β induces cellular injury in experimental diabetic neuropathyExperimental Neurology, 2008
- Diabetes impairs DRG neuronal attachment to extracellular matrix proteins in vitroBrain Research Bulletin, 1995
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Increased matrix gene expression by glucose in rat neural connective tissue cells in cultureDiabetes, 1991
- Scleroderma-like Changes in Insulin-dependent Diabetes Mellitus: Clinical and Biochemical StudiesDiabetes Care, 1984